Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

BACKGROUND: Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvant...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Chouairi, Fouad, Mullan, Clancy W., Sen, Sounok, Mori, Makoto, Fuery, Michael, Elder, Robert W., Lesse, Joshua, Norton, Kelsey, Clark, Katherine A., Miller, P. Elliott, Mulligan, David, Formica, Richard, Rogers, Joseph G., Jacoby, Daniel, Maulion, Christopher, Anwer, Muhammad, Geirsson, Arnar, Desai, Nihar R., Ahmad, Tariq
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7924739/
https://ncbi.nlm.nih.gov/pubmed/33651802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247789
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia